Travere Therapeutics (TVTX) Amortizatization of Intangibles (2011 - 2023)
Travere Therapeutics posted quarterly Amortizatization of Intangibles of $2.3 million for Q4 2023, up 122.39% year-on-year from $1.0 million in Q4 2022, and up 22.84% on a QoQ basis from $1.9 million in Q3 2023.
Travere Therapeutics (TVTX) has 11 years of Amortizatization of Intangibles data on file, last reported at $2.3 million in Q4 2023.
- For the quarter ending Q4 2023, Amortizatization of Intangibles rose 122.39% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2023 stood at $5.7 million (up 717.43% YoY), and the FY2025 full-year result was $4.4 million, down 2.18% from the prior year.
- Amortizatization of Intangibles for Q4 2023 stood at $2.3 million, up from $1.9 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.3 million in Q4 2023 and bottomed at -$697000.0 in Q4 2021.
- The 5-year median for Amortizatization of Intangibles is -$155500.0 (2020), against an average of $161333.3.
- The widest annual swing landed in 2019, when Amortizatization of Intangibles soared 295.1%; it then tumbled 2022.22% in 2020.
- A 5-year view of Amortizatization of Intangibles shows it stood at $9000.0 in 2019, then sank by 2022.22% to -$173000.0 in 2020, then tumbled by 302.89% to -$697000.0 in 2021, then jumped by 246.77% to $1.0 million in 2022, then surged by 122.39% to $2.3 million in 2023.
- The last three Amortizatization of Intangibles figures came in at $2.3 million (Q4 2023), $1.9 million (Q3 2023), and $1.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 572,000.00 |
| Sep 30, 2022 | 572,000.00 |
| Jun 30, 2022 | -222,000.00 |
| Jun 30, 2022 | -222,000.00 |
| Mar 31, 2022 | -673,000.00 |
| Mar 31, 2022 | -673,000.00 |
| Dec 31, 2021 | -697,000.00 |
| Dec 31, 2021 | -697,000.00 |
| Sep 30, 2021 | -651,000.00 |
| Sep 30, 2021 | -651,000.00 |
| Jun 30, 2021 | -483,000.00 |
| Jun 30, 2021 | -483,000.00 |
| Mar 31, 2021 | -177,000.00 |
| Mar 31, 2021 | -177,000.00 |
| Dec 31, 2020 | -173,000.00 |
| Dec 31, 2020 | -173,000.00 |
| Sep 30, 2020 | -193,000.00 |
| Sep 30, 2020 | -193,000.00 |
| Jun 30, 2020 | -199,000.00 |
| Jun 30, 2020 | -199,000.00 |
| Mar 31, 2020 | -138,000.00 |
| Mar 31, 2020 | -138,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 199,000.00 |
| Sep 30, 2019 | 199,000.00 |
| Jun 30, 2019 | 237,000.00 |
| Jun 30, 2019 | 237,000.00 |
| Mar 31, 2019 | 343,000.00 |
| Mar 31, 2019 | 343,000.00 |
| Dec 31, 2018 | 367,000.00 |
| Dec 31, 2018 | 367,000.00 |
| Sep 30, 2018 | -102,000.00 |
| Sep 30, 2018 | -102,000.00 |
| Jun 30, 2018 | -291,000.00 |
| Jun 30, 2018 | -291,000.00 |
| Mar 31, 2018 | -356,000.00 |
| Mar 31, 2018 | -356,000.00 |
| Dec 31, 2017 | -1.34 Mn |
| Dec 31, 2017 | -1.34 Mn |
| Sep 30, 2017 | 602,000.00 |
| Sep 30, 2017 | 602,000.00 |
| Jun 30, 2017 | -315,000.00 |
| Jun 30, 2017 | -315,000.00 |
| Mar 31, 2017 | -287,000.00 |
| Mar 31, 2017 | -287,000.00 |
| Dec 31, 2016 | 1.95 Mn |
| Dec 31, 2016 | 1.95 Mn |
| Sep 30, 2016 | -187,000.00 |
| Sep 30, 2016 | -187,000.00 |
| Jun 30, 2016 | -277,000.00 |
| Jun 30, 2016 | -277,000.00 |
| Mar 31, 2016 | -389,000.00 |
| Mar 31, 2016 | -389,000.00 |
| Dec 31, 2015 | 398,000.00 |
| Dec 31, 2015 | 398,000.00 |
| Dec 31, 2014 | -534,005.00 |
| Dec 31, 2014 | -534,005.00 |
| Sep 30, 2014 | 478,005.00 |
| Sep 30, 2014 | 478,005.00 |
| Nov 30, 2011 | 500.00 |
| Nov 30, 2011 | 500.00 |